Attention - PubMed
Review
Attention
Patrick M Callahan et al. Handb Exp Pharmacol. 2015.
Abstract
The ability to focus one's attention on important environmental stimuli while ignoring irrelevant stimuli is fundamental to human cognition and intellectual function. Attention is inextricably linked to perception, learning and memory, and executive function; however, it is often impaired in a variety of neuropsychiatric disorders, including Alzheimer's disease, schizophrenia, depression, and attention deficit hyperactivity disorder (ADHD). Accordingly, attention is considered as an important therapeutic target in these disorders. The purpose of this chapter is to provide an overview of the most common behavioral paradigms of attention that have been used in animals (particularly rodents) and to review the literature where these tasks have been employed to elucidate neurobiological substrates of attention as well as to evaluate novel pharmacological agents for their potential as treatments for disorders of attention. These paradigms include two tasks of sustained attention that were developed as rodent analogues of the human Continuous Performance Task (CPT), the Five-Choice Serial Reaction Time Task (5-CSRTT) and the more recently introduced Five-Choice Continuous Performance Task (5C-CPT), and the Signal Detection Task (SDT) which was designed to emphasize temporal components of attention.
Similar articles
-
Talpos J, Shoaib M. Talpos J, et al. Handb Exp Pharmacol. 2015;228:191-213. doi: 10.1007/978-3-319-16522-6_6. Handb Exp Pharmacol. 2015. PMID: 25977083
-
Animal paradigms to assess cognition with translation to humans.
Wallace TL, Ballard TM, Glavis-Bloom C. Wallace TL, et al. Handb Exp Pharmacol. 2015;228:27-57. doi: 10.1007/978-3-319-16522-6_2. Handb Exp Pharmacol. 2015. PMID: 25977079 Review.
-
[No authors listed] [No authors listed] Handb Exp Pharmacol. 2015;228:157-9. Handb Exp Pharmacol. 2015. PMID: 26317140 No abstract available.
-
Methods for delivering and evaluating the efficacy of cognitive enhancement.
Harvey PD, Keefe RS. Harvey PD, et al. Handb Exp Pharmacol. 2015;228:5-25. doi: 10.1007/978-3-319-16522-6_1. Handb Exp Pharmacol. 2015. PMID: 25977078 Review.
-
Preface to cognitive enhancement.
Kantak KM, Wettstein JG. Kantak KM, et al. Handb Exp Pharmacol. 2015;228:v. Handb Exp Pharmacol. 2015. PMID: 26317138 No abstract available.
Cited by
-
Dauwan M, Begemann MJ, Heringa SM, Sommer IE. Dauwan M, et al. Schizophr Bull. 2016 May;42(3):588-99. doi: 10.1093/schbul/sbv164. Epub 2015 Nov 7. Schizophr Bull. 2016. PMID: 26547223 Free PMC article. Review.
-
The role of the medial prefrontal cortex in cognition, ageing and dementia.
Jobson DD, Hase Y, Clarkson AN, Kalaria RN. Jobson DD, et al. Brain Commun. 2021 Jun 11;3(3):fcab125. doi: 10.1093/braincomms/fcab125. eCollection 2021 Jul. Brain Commun. 2021. PMID: 34222873 Free PMC article. Review.
-
Wang LJ, Chan WC, Chou MC, Chou WJ, Lee MJ, Lee SY, Lin PY, Yang YH, Yen CF. Wang LJ, et al. Sci Rep. 2017 Apr 3;7:45595. doi: 10.1038/srep45595. Sci Rep. 2017. PMID: 28367959 Free PMC article.
-
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.
Terry AV Jr, Callahan PM, Hernandez CM. Terry AV Jr, et al. Biochem Pharmacol. 2015 Oct 15;97(4):388-398. doi: 10.1016/j.bcp.2015.07.027. Epub 2015 Jul 29. Biochem Pharmacol. 2015. PMID: 26231940 Free PMC article. Review.
-
Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach.
Navarro D, Gasparyan A, Martí Martínez S, Díaz Marín C, Navarrete F, García Gutiérrez MS, Manzanares J. Navarro D, et al. Int J Mol Sci. 2023 Apr 21;24(8):7653. doi: 10.3390/ijms24087653. Int J Mol Sci. 2023. PMID: 37108813 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical